Recombinant human thyrotropin stimulation prior to 131I therapy in toxic multinodular goiter with low radioactive iodine uptake

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Revista Espanola De Medicina Nuclear

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.REMNIE.2016.10.003
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A Review of the Pathogenesis and Management of Multinodular Goiter

  2014cited by this paper
• Long-Term Efficacy of Modified-Release Recombinant Human Thyrotropin Augmented Radioiodine Therapy for Benign Multinodular Goiter: Results from a Multicenter, International, Randomized, Placebo-Controlled, Dose-Selection Study

  2014cited by this paper
• Recombinant human thyrotropin (rhTSH) aided radioiodine treatment for non‐toxic multinodular goitre

  2013cited by this paper
• Prestimulation with recombinant human thyrotropin (rhTSH) improves the long-term outcome of radioiodine therapy for multinodular nontoxic goiter.

  2012cited by this paper
• Radioiodine therapy of benign non-toxic goitre. Potential role of recombinant human TSH.

  2011cited by this paper
• EANM procedure guidelines for therapy of benign thyroid disease

  2010cited by this paper
• Recombinant human thyrotropin-stimulated radioiodine therapy of nodular goiter allows major reduction of the radiation burden with retained efficacy.

  2010cited by this paper
• Role of recombinant human TSH in the management of large euthyroid multinodular goitre: a new therapeutic option? Pros and cons.

  2010cited by this paper
• [Intrathoracic goitre: a literature review].

  2010cited by this paper
• Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.

  2009cited by this paper
• Optimizing 131I Uptake After rhTSH Stimulation in Patients with Nontoxic Multinodular Goiter: Evidence from a Prospective, Randomized, Double-Blind Study

  2009cited by this paper
• Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration.

  2008cited by this paper
• Improvement of goiter volume reduction after 0.3 mg recombinant human thyrotropin-stimulated radioiodine therapy in patients with a very large goiter: a double-blinded, randomized trial.

  2007cited by this paper
• Stimulation with 0.3-mg recombinant human thyrotropin prior to iodine 131 therapy to improve the size reduction of benign nontoxic nodular goiter: a prospective randomized double-blind trial.

  2006cited by this paper
• Transient goiter enlargement after administration of 0.3 mg of recombinant human thyrotropin in patients with benign nontoxic nodular goiter: a randomized, double-blind, crossover trial.

  2006cited by this paper
• Low-dose recombinant human thyrotropin-aided radioiodine treatment of large, multinodular goiters in elderly patients.

  2006cited by this paper
• Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH)

  2006cited by this paper
• 123I thyroid uptake and thyroid size at 24, 48, and 72 hours after the administration of recombinant human thyroid-stimulating hormone to normal volunteers.

  2006cited by this paper
• Recombinant human thyrotropin markedly changes the 131I kinetics during 131I therapy of patients with nodular goiter: an evaluation by a randomized double-blinded trial.

  2005cited by this paper
• Hyperthyroidism: diagnosis and treatment.

  2005cited by this paper
• Pretreatment with a single, low dose of recombinant human thyrotropin allows dose reduction of radioiodine therapy in patients with nodular goiter.

  2003cited by this paper
• Utilidad del tratamiento con yodo radiactivo en el bocio multinodular normofuncionante

  2002cited by this paper
• Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters.

  2001cited by this paper
• Administration of a single low dose of recombinant human thyrotropin significantly enhances thyroid radioiodide uptake in nontoxic nodular goiter.

  2000cited by this paper
• Cancer mortality after iodine‐131 therapy for hyperthyroidism

  1992cited by this paper
• Radioiodine therapy in voluminous multinodular non-toxic goitre.

  1990cited by this paper
• Iodine-131: optimal therapy for hyperthyroidism in children and adolescents?

  1979cited by this paper

• Planning and diagnostic nursing strategy in the clinical management of the patient with hyperthroidism

  2022cites this paper
• Recombinant human thyrotropin (rhTSH)-aided radioiodine treatment for non-toxic multinodular goitre.

  2021cites this paper
• Recombinant Human Thyrotropin-Stimulated Radioiodine Therapy in Patients with Multinodular Goiters: A Meta-Analysis of Randomized Controlled Trials

  2020cites this paper
• Treatment of thyrotoxicosis with radioiodine (аnalytical review of literature and own clinical data)

  2020cites this paper